NSE: MPHASIS | BSE: 526299

Mid-range Performer

Download real time

2467.00 6.30 (0.26%)

52W Low on Apr 07, 2025

96,694 NSE+BSE Volume

NSE 05 May, 2025 11:12 AM (IST)

46,891.9

Market Cap

High in industry

1.2

Beta 1Year

Very High Volatility

MphasiS Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MPHASIS, BSE:526299 MphasiS Ltd.

MphasiS Ltd.

23 Oct 2020

2467.00

0.26%

Mphasis (REDUCE): DXC remains soft but pipeline healthy raise to REDUCE

Sell: MphasiS Ltd.

Target

BOB Capital Markets Ltd.

Mphasis (MPHL) reported strong Q2FY21 revenue and margins.

MphasiS Ltd. is trading above its 50 day SMA of 2386.9

MphasiS Ltd.

23 Oct 2020

2467.00

0.26%

Mphasis Ltd.

Buy: MphasiS Ltd.

Recommendation Target

ICICI Securities Limited

Number of FII/FPI investors increased from 1002 to 1016 in Mar 2025 qtr.

MphasiS Ltd.

27 Jul 2020

2467.00

0.26%

Q1FY21 Result Update - Strong, Steady, Resilient! - Upgrade to 'BUY'

Accumulate: MphasiS Ltd.

Target

Prabhudas Lilladhar

Deal pipeline was the highlight for the quarter- New deal wins highest ever at $259mn, +29% QoQ, +72% YoY. It includes a large deal win of US$105mn. In addition, the company signed another large deal of $216mn deal in July, from...

Anand Rathi decreased Buy price target of MphasiS Ltd. to 3008.0 on 28 Apr, 2025.

MphasiS Ltd.

25 Jul 2020

2467.00

0.26%

Deal wins and outlook surprise!

Neutral: MphasiS Ltd.

Target

Motilal Oswal

Direct International (DI) revenues were largely stable, while DXC revenue witnessed sharp decline (16% QoQ, CC). EBIT margin contraction was largely led by a sharp fall in While S&M; expenses remained stable (as % of revenue), pressure at the gross margin level was partially offset by G&A; rationalization (~150bp QoQ). While the DXC business (~20% of revenues) is expected to be under pressure in the near term, Direct International should continue to drive overall performance. While MRC of USD250m (up to Sep21) is still due, management expects the DXC In 1QFY21, revenue (USD) / EBIT (INR) / PAT increased by 3%/12%/4% YoY v/s International (DI) revenues were largely stable, while DXC revenue witnessed estimates. EBIT margin contraction was largely led by a sharp fall in utilization While S&M; expenses remained stable (as % of revenue), pressure at the gross margin level was partially offset by G&A; rationalization (~150bp QoQ).

MphasiS Ltd. has an average target of 2685.80 from 5 brokers.

MphasiS Ltd.

24 Jul 2020

2467.00

0.26%

Mphasis (SELL): Strong deal wins; DXC remains soft

Sell: MphasiS Ltd.

Target

BOB Capital Markets Ltd.

Mphasis (MPHL) reported weak revenue but an operating margin beat in Q1FY21.

MphasiS Ltd. has an average target of 2685.80 from 5 brokers.

MphasiS Ltd.

24 Jul 2020

2467.00

0.26%

Mphasis Ltd.

Hold: MphasiS Ltd.

Recommendation Target

ICICI Securities Limited

Revenues to witness improving trend led by healthy pipeline Mphasis has major exposure to BFSI (~60% of revenues) and information, communication & entertainment (~15% of revenues), which are relatively less impacted by Covid 19 pandemic vs. travel & hospitality verticals. Further, lower legacy exposure and higher growth in digital technology puts the company in a sweet spot. This resulted in Mphasis seeing increase in new deal wins (up 66% YoY in Q1FY21, 38% YoY in Q2FY21E) of which 79% of TCV is in new generation technology. Further, it has also seen healthy...

MphasiS Ltd. has an average target of 2685.80 from 5 brokers.

MphasiS Ltd.

30 Jun 2020

2467.00

0.26%

MphasiS

Buy: MphasiS Ltd.

Target

Dolat Capital

Mphasis had an event full year as it tested the company's ability to sustain the tough times (HP/DXC channel revenues grew just 7.7% dragging the overall traction; rest business grew 17%) and deliver growth by focusing on its core strategy of providing efficiency, reducing cost and fulfilling need of clients by bringing T back to IT' through cloud and cognitive technology, Dev opps, Cloud native app dev, legacy modernization, Enterprise Automation, Next gen data etc. Strong digital capabilities led to strong traction both in revenue growth (revenues up 14% in FY20) as well as order...

Anand Rathi decreased Buy price target of MphasiS Ltd. to 3008.0 on 28 Apr, 2025.

MphasiS Ltd.

14 May 2020

2467.00

0.26%

Decent performance; Soft outlook!

Neutral: MphasiS Ltd.

Target

Motilal Oswal

4QFY20 revenue growth at 1.5% (QoQ, CC) was marginally behind our estimates, as weakness in DXC channel overshadowed the healthy performance in Direct. Direct Core segment has been the growth driver and has seen strong deal In terms of capital allocation, MPHL will maintain its 55-57% payout policy. Maintain Given the uncertainty in the environment, management hinted at a soft outlook on revenue growth. However, the company is confident of maintaining its margins by using levers such as increase in share of Fixed Price Projects, fresher hiring, pyramid rationalization, automation and reduced travel costs etc. Direct Core segment has been the growth driver and has seen strong deal wins, Geography wise, Americas declined 1% QoQ while growth in Europe / RoW grew strong at 8%/9%.

Anand Rathi decreased Buy price target of MphasiS Ltd. to 3008.0 on 28 Apr, 2025.

MphasiS Ltd.

14 May 2020

2467.00

0.26%

Mphasis (SELL): HP-DXC business losing steam; downgrade to SELL

Sell: MphasiS Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Mphasis (MPHL) reported a satisfactory Q4 on the back of (1) 1.5% QoQ/11.1% YoY CC revenue growth, (2) stable 16.3% EBIT margins, and (3) healthy deal wins.

Anand Rathi decreased Buy price target of MphasiS Ltd. to 3008.0 on 28 Apr, 2025.

MphasiS Ltd.

14 May 2020

2467.00

0.26%

Mphasis Ltd.

Buy: MphasiS Ltd.

Recommendation Target

ICICI Securities Limited

The company is undertaking various measures for cost rationalisation like lower travel cost and lower discretionary spend. However, subdued revenues in DXC channel and anticipated utilisation pressure in the near term will impact FY21E margins. Hence, we expect FY21E EBIT margins to decline 90 bps YoY to 15.1% and see a recovery in FY22E leading to an...

Number of MF schemes increased from 213 to 221 in Mar 2025 qtr.

Is MphasiS Ltd. worth buying?

244 Votes:

Buy 78.69%

Sell 12.3%

Hold 9.02%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Neutral SEE REPORTS >

pdf